Kunwar Shailubhai, © Tiziana Life Sciences

Tiziana Life Sciences: Putting research first

AIM-listed Tiziana Life Sciences has a new head: The clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases appointed Kunwar Shailubhai Chief Executive Officer and Chief Scientific Officer.

Shailubhai was previously a Non-Executive Director at Tiziana. His appointment follows many years working at Synergy Pharmaceuticals Inc., which he co-founded and where he served as Chief Scientific Officer since 2008. 

Prior to joining Tiziana Life Sciences and Synergy Life Sciences, he worked at Callisto Pharmaceuticals, Monsanto and as a senior staff fellow at the National Institutes of Health (NIH).